Cargando…
PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects
During acute cardiac ischaemia/reperfusion (I/R), an increased plasma proprotein convertase subtilisin/kexin 9 (PCSK9) level instigates inflammatory and oxidative processes within ventricular myocytes, resulting in cardiac dysfunction. Therefore, PCSK9 inhibitor (PCSK9i) might exert cardioprotection...
Autores principales: | Palee, Siripong, McSweeney, Christian M., Maneechote, Chayodom, Moisescu, Dalila M., Jaiwongkam, Thidarat, Kerdphoo, Sasiwan, Chattipakorn, Siriporn C., Chattipakorn, Nipon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815840/ https://www.ncbi.nlm.nih.gov/pubmed/31557388 http://dx.doi.org/10.1111/jcmm.14586 |
Ejemplares similares
-
Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury
por: Maneechote, Chayodom, et al.
Publicado: (2017) -
Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation
por: Apaijai, Nattayaporn, et al.
Publicado: (2019) -
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
por: Lahnwong, Sarayut, et al.
Publicado: (2020) -
PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca(2+) regulation
por: Amput, Patchareeya, et al.
Publicado: (2020) -
Melatonin as a therapy in cardiac ischemia-reperfusion injury: Potential mechanisms by which MT2 activation mediates cardioprotection
por: Singhanat, Kodchanan, et al.
Publicado: (2020)